A Study of Strategic Alliances and Competitive Advantages of the Biochip firms in Taiwan

• Main Authors: Chih-Kang Shen, 沈志剛
• Other Authors: York Y. Wu
• Format: Others
• Language: zh-TW
• Published: 2001
• Online Access: http://ndltd.ncl.edu.tw/handle/99750088676203605211

碩士 === 國立交通大學 === 經營管理研究所 === 89 === ABSTRACT Biotechnology is one of the most potential high-tech industries for the 21st century. Especially, human genome draft was published. The subject of this study is to examine how the biochip firms build competitive advantages through the resources acquired from strategic alliances. This study was carried by interviewing managers of three biochip companies in Taiwan: U-Vision Biotech Inc., DR. Chip Biotech Inc. and Taiwan Genome Sciences Inc. and collecting second class information and then analysis the future of biochip marketplace in Taiwan. Finally, I have some suggestion for someone who wants to operate a biochip company. The results of this study indicates that the competitive advantages of Taiwan’s biochip firms are: Academia Sinica provided technologies of making biochip and data analysis and the Industrial Technology Research Institute gave so much help in product commercialization. Furthermore, there are many well-educated researchers and production engineers here. It is very important that they collaborated with foreign Chinese biotech experts in developing biochip. Biochip companies should cooperate with research institutes, semiconductor and micro-electronic-mechanical workers to develop new generation biochips and make attention on particular Asia diseases for research then they would have the chance to make success.